Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications
5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: April 24, 2015
Showing 1-1 of 1
Last Updated: 09/26/2026